AI in Oral Cancer Screening

Oral cancer screening research uses computer vision to analyze photographs, clinical images or digitized pathology slides for visual patterns associated with oral potentially malignant disorders or cancer. A model may classify an image or mark a region for a trained professional to inspect. This is a research and decision-support task: a photo classifier does not take a history, examine tissue, perform a biopsy or confirm pathology. A suspicious result needs appropriate assessment; a reassuring score should not be treated as proof that disease is absent. Published reviews report promising results in selected datasets but also differences in imaging methods, study designs, reference standards and risk of bias. A 2024 review of oral mucosa lesion photographs concluded that expected accuracy gains and health benefits remained unclear. Another 2024 review across diagnostic imaging found varying performance and called for further evaluation. Results from image collections do not automatically transfer to community screening, different cameras, lighting, lesion types or populations. Metrics measured in a study are not guarantees for a particular patient. For now, AI is best described as a possible aid for prioritizing images or drawing attention to an area, under professional oversight and within a validated workflow. It should not be used to self-diagnose, reassure someone that a persistent lesion is harmless, or delay dental or medical evaluation. Clinical decisions require qualified examination and, when indicated, further diagnostic testing. Researchers and health systems need prospective studies that test real workflows, false negatives, false alarms, access and patient outcomes. An alert can start a conversation; it cannot replace clinical judgment or tissue diagnosis.